Comparison of myeloma cells to the two B-lymphoblastoid cell lines also showed CD138/SDC1 and CD28 as characterizing myeloma cells, while CD19, CD22, and CD20 characterized late-stage B-cells. This evidence concerns the gene CD28 and plasma cell myeloma.